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Calponin is an actin-, calmodulin-, and tropomyosin-binding protein that has been isolated from smooth muscle tissue. Using a monoclonal anti- 
body specific for avian calponin, we demonstrate a differentiation-linked increase in calponin expression i  embryonic hick gizzard. Cultivation 
of gizzard smooth muscle cells in vitro resulted in a down-regulation f calponin expression after the first 48 h that was paralleled by a loss of 
synthesis of metavinculin and the high molecular weight isoform of caldesmon. In early cultures of smooth muscle cells calponin was localised 
in the actin-containing stress fibres but labelling was restricted to the central parts of the actin cytoskeleton. Calponin expression is suggested as 
a potentially useful index of smooth muscle differentiation. 
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1. INTRODUCTION 
Calponin is a 34 kDa actin- and calmodulin-binding 
protein originally purified from vertebrate smooth mus- 
cle tissue by Takahashi and colleagues [1]. From the 
demonstrated binding of calponin also to tropomyosin 
[2,3], its apparent presence in native thin filaments 
isolated from smooth muscle [4] and its in vitro inhibi- 
tion of smooth muscle actomyosin ATPase [4,5] this 
protein has been attributed with a regulatory role in the 
contractile machinery. While it has been shown that 
calponin is absent from certain non-muscle tissues [6], 
it has not been demonstrated how the expression of 
calponin correlates with the differentiation state of 
smooth muscle cells. In this report we show that 
calponin accumulates during smooth muscle differen- 
tiation and isappears concomittantly with two already 
established smooth muscle markers, metavinculin and 
the heavy caldesmon isoform, during proliferation of 
smooth muscle cells in vitro. 
2. MATERIALS AND METHODS 
2.1. Electrophoresis 
Analytical gel electrophoresis was carried out on 8-22% acrylamide 
minislab gels according to the procedure of Matsudaira nd Burgess 
[7] in the buffer system of Laemmli [8]. Protein samples were sup- 
plemented with SDS sample buffer (final concentrations: 2.5% SDS, 
1°7o 2-mercaptoethanol, 7070 glycerol, 0.001070 Bromophenol blue, 
62.2 mM Tris, pH 6.8) and boiled for 1 min at 100°C. The gels were 
stained for 30 rain at 60°C in 0.2070 Coomassie brilliant blue G250 
(Sigma) dissolved in 50°70 methanol and 10% acetic acid and destained 
in 10% acetic acid at 70°C. 
Whole muscle samples from embryos and adult gizzard were weigh- 
ed and dissolved at a fixed concentration i the sample buffer and 
equal amounts applied to the gels. 
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2.2. Immunological techniques 
Blotting of minislab gels onto nitrocellulose sheets (Schleicher and 
Schuell, FRG) was performed according to Towbin et al. [9] and 
silver-enhanced immunogold-staining carried out as described by 
Moeremans et al. [10] using a secondary antibody with a 20-nm gold 
tag (Janssen Pharmaceutica, Belgium). Monoclonal antibodies to vin- 
culin, calponin and caldesmon, used for immunoblotting, were from 
Sigma (vin 11-5, CP-93 and Clone C 0297, respectively). 
Monoclonal antibody to calponin clone CP-93 was derived from a 
fusion between a mouse myeloma cell line P3-NS1-Ag 41 and 
splenocytes from BALB/c mice immunized with turkey gizzard 
calponin following standard procedures of hybridoma technology. 
Positive wells were selected using multiple-slot immunoblotting and 
immunofluorescence labeling. Clone CP-93 was found to be of IgGl 
subclass determined by Sigma Immunotype kit (Sigma, St. Louis). 
2.3. Primary cultures 
Cultured cells were prepared from gizzards taken from 16-day-old 
chick embryos using collagenase (3 mg/ml) for cell dispersion. 
Cultures were maintained in DMEM containing 10070 fetal calf serum 
at 37°C in the presence of 5% CO2. 
2.4. Fluorescence microscopy 
Cultured chick gizzard cells were fixed in a mixture of Triton X-100 
(0.2%) and paraformaldehyde (3070) in cytoskeleton buffer [11] for 30 
rain at room temperature. They were then processed for im- 
munofluorescence microscopy essentially as described elsewhere [12]. 
The polyclonal antibody against chicken vinculin was kindly provided 
by Prof. B. Geiger (Weizmann Institut, Israel) and the rhodamine- 
and coumarin-conjugated phalloidins by Prof. H. Faulstich (Max- 
Planck-lnstitute, Heidelberg). 
3. RESULTS AND DISCUSSION 
The differentiation of gizzard smooth muscle in situ 
has formerly been shown to be accompanied by 
characteristic changes in the expression of cytoskeletal 
and contractile proteins. These include increases in the 
expression of desmin [13,14], caldesmon [15], metavin- 
culin [16], the smooth muscle isoforms of tropomyosin 
[17], and changes in the myosin light chain pattern 
[18,19]. Using a monoclonal antibody that labels only 
calponin in total extracts of gizzard muscle (Fig. 1), we 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/$3.50 © 1990 Federation of European Biochemical Societies 159 
Volume 274, number 1,2 FEBS LETTERS November 1990 
1 2 3 4 
t 
t 
A~ B '  C,: D' E ~: 
i :¸¸ !/!ilL!il/ 
i ~:ii::i ~::: :/ : / i : : /  : 
Fig. 3. Absence of calponin from skeletal muscle and non-muscle 
tissues. Samples hown in gel (left) and corresponding immunoblot 
with the calponin antibody (right) are of the following chicken tissues: 
(A,B) skeletal muscles, respectively scapulohumeralis posterior and 
biceps propatagialis; (C) kidney; (D) liver; (E) spleen. 
Fig. 1. Immunoblot with monoclonal CALP 93 antibody. (1 and 3) 
Coomassie-stained g ls of total turkey gizzard smooth muscle xtract 
(1) and purified calponin (3). (2 and 4) Corresponding immunoblots. 
In addition to intact calponin, the antibody stains the 31 kDa pro- 
teolytic fragment: a single band is labelled in gels of the whole muscle 
extract. Arrows indicate filamin, myosin heavy chain, caldesmon, ac- 
tin and calponin (from top to bottom). 
have shown that  there is also a d i f ferent iat ion- l inked in-
crease in ca lpon in  expression in embryon ic  chick giz- 
zard (Fig. 2). 
In  agreement  with the data  f rom Takahash i  et al. [6] 
non-musc le  t issues, k idney,  l iver and  spleen, were 
negat ive for ca lpon in  (Fig. 3C-E) .  We were also 
unab le ,  with out  monoc lona l  ant ibody ,  to detect any  
immunoreact ion  in extracts o f  both  skeletal muscle 
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Fig. 2. Expression of calponin in embryonic chick gizzard during development. Samples hown in gel (left) and corresponding immunoblot with 
the calponin antibody (right) are: (A-G) embryonic gizzards taken at, respectively, 12, 13, 14, 15, 16, 7 and 19 days of incubation and H, adult 
chicken gizzard. 
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Fig. 4. Down-regulation f calponin expression in gizzard smooth 
muscle cells cultured in vitro; correlation with expression of 
caldesmon and metavinculin. Immunoblot sh ws samples taken 
from: (1) 16-day embryo gizzard; (2-4) primary culture of 16-day giz- 
zard cells sampled at 3, 24 and 48 h, respectively; (5)same cells as in 
2-4 but at 72 h, 24 h after the first replating. The same samples were 
blotted with antibodies to caldesmon (A), vinculin (B) and calponin 
(C). Abbreviations: CaD, caldesmon; arrow and arrowhead indicate 
heavy and light isoforms of caldesmon, respectively; V, vinculin 
(open circle); MV, metavinculin (filled circle); CN, calponin. 
(Fig. 3A,B) and cardiac muscle (not shown). The 
absence of a cross-reaction i  skeletal muscle differs 
from that observed by Takahashi and colleagues [20] 
who detected a weak labelling of Troponin T; we 
presume that the polyclonal antibody used by them con- 
tained fractions reactive with troponin T-like epitopes 
on the molecule, not recognised by our antibody. 
When cells from 16-day chick embryo gizzards were 
taken into culture, they continued to express ubstantial 
amounts of calponin during the first 24 h (Fig. 4C, 
lanes 2 and 3). However, there was a subsequent, 
dramatic drop in calponin synthesis that was unaffected 
by the cells reaching confluency (Fig. 4C, lane 4; 48 h). 
Following the first passage practically no calponin 
could be detected by immunoblotting (Fig. 4C, lane 5; 
72 h). These changes in calponin synthesis in cultured 
cells in vitro paralleled the loss of metavinculin 
(Fig. 4B) and the switch from the heavy to the light 
isoform of caldesmon in the same samples (Fig. 4A). 
Changes in expression of the latter two proteins on 
cultivation of smooth muscle cells in vitro have been 
earlier documented [15,21]. 
Immunofluorescence microscopy showed that 
calponin was localised in the actin-containing stress 
fibres of gizzard ceils (Fig. 5A,B; 24 h). Interestingly, 
the entire length of the stress fibres was not labelled. 
Characteristically, the actin bundles were unstained at 
Fig. 5. Colocalization ofcalponin with a subset of actin filaments in primary cultures of 16-day chick embryo gizzard. (A) actin; (B) calponin; 
(C-E) triple immunofluorescence microscopy ofsame cells shows absence of calponin from actin filaments in the region ofvinculin rich contacts. 
(C) actin; (D) calponin; (E) vinculin. 
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their extreme nds where they approached the sub- 
s t rate-membrane anchorage sites, marked by vinculin 
ant ibodies (Fig. 5C-E).  In the cell cultures, we typical ly 
found cells that were completely unstained for calponin 
and the proport ion  of  these cells increased with culture 
t ime. 
The restr ict ion of  calponin expression only to smooth 
muscle points to a tissue-specif ic funct ion of  this pro- 
tein, the details of  which are now under investigation 
[3-5]. A l though isoelectric variants of  calponin exist 
([20] and our unpubl ished observations),  which may 
arise from different levels of  phosphory lat ion [5], there 
is apparent ly  only one molecular  weight isoform of  this 
protein,  with the apparent  molecular  weight varying 
somewhat  between species [3,20]. Ant ibodies to 
calponin may therefore be of  part icular value as com- 
p lementary and alternative markers of  smooth muscle 
di f ferentat ion.  
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